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The outlook for pregnancy in gravidas with kid-
ney disorders and the effect of gestation on the re-
mote outcome of the underlying disease remain un-
certain, and conception in such women continues to
generate anxiety for them as well as their physi-
cians. There is general agreement that a moderately
severe decrease in renal function (that is, a serum
creatinine concentration in excess of 2 mgldl), espe-
cially in the presence of significant hypertension,
reduces drastically the chances for conception, and
all the more for a successful outcome of the gesta-
tion [1-7]. Women with preserved kidney function
and normal blood pressure have an increased in-
cidence of preeclampsia; but except for this compli-
cation, the outlook for the pregnancy does not seem
to be worse than it is in other gravidas [1-7]. The
situation is less clear in regards to the effects of ges-
tation on the mother's kidney disease: Most investi-
gators believe that pregnancy does not affect ad-
versely the natural course of renal disorders as long
as kidney function is, at most, mildly impaired and
hypertension is absent at conception [1, 3—11]. In
contrast, several reports in the older literature (re-
viewed in Ref. 2) and more recent studies describ-
ing mainly patients from Australia maintain that in
such women pregnancy often leads to a worsening
of the morphologic lesions and a deterioration of
renal function [12—15]. The cause of these divergent
views is not readily apparent, but it is probably due
in no small measure to the lack of studies where the
diagnosis was established by renal biopsy and in
which clinical, functional, and pathologic observa-
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tions were correlated in sufficiently large numbers
of gravidas studied prospectively.
We organized the present study as a joint project
between three medical centers with a long-standing
interest in the subject, in order to include a large
number of patients originating from various types of
medical practice and geographic location: The Uni-
versity of Chicago Lying-in Hospital is a perinatal
referral center that also serves a large inner-city
population; Yale University School of Medicine is a
referral center for most of the State of Connecticut;
and the Princess Mary Maternity Hospital serves
the population of Newcastle-upon-Tyne and the
surrounding area of Northern England. Analysis of
renal-function profiles and pregnancy outcome was
based on the same criteria for patients from all three
centers. The gravidas were selected for inclusion in
the study by the availability of a biopsy diagnosis,
and their course was studied through subsequent
gestations, if any, or for various periods until the
end of followup. This survey represents therefore a
combined prospective and retrospective study that,
although not free of some of the shortcomings of
earlier reports, we hope contributes useful informa-
tion on a subject of obvious interest to obstetricians
and nephrologists alike.
Methods
This study analyses the outcome of 121 preg-
nancies and the effect of gestation on the underlying
disease in 89 women with various renal disorders.
All women included in this survey were cared for
between 1956 and 1979 at three medical centers:
The University of Chicago School of Medicine, Chi-
cago, Illinois (48 patients); Yale University School
of Medicine, New Haven, Connecticut (15 pa-
tients); and the University of Newcastle Medical
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School, Princess Mary Maternity Hospital, New-
castle-upon-Tyne, United Kingdom (26 patients).
Criteria for inclusion in the study were availability
of a tissue diagnosis, continuation of pregnancy
beyond the first trimester, and sufficient data to per-
mit evaluation of either the outcome of pregnancy
or of its effect on the mother's renal disease. Preg-
nancies ending in therapeutic abortion were not in-
cluded because it was often not possible to ascer-
tain the reason why it was performed.
In all cases, the diagnosis was established by kid-
ney biopsy, except for one patient in the Chicago
series with bilateral renal artery stenosis diagnosed
by arteriography. Another patient in the Chicago
series had arterioloscierosis and the characteristic
lesion of preeclampsia in the biopsy performed
postpartum, but was later found to have polycystic
kidney disease. In the Chicago and New Haven se-
ries, tissue was examined by both light and electron
microscopy, and often also by immunofluores-
cence; in the Newcastle series, with one excep-
tion, biopsies were examined by light micros-
copy alone. In general, the biopsy was performed
before the index pregnancy in the Newcastle series,
and the course of the disease was followed prospec-
tively through subsequent gestations. In contrast,
the majority of women in the Chicago series had no
previous knowledge of renal disease until the index
pregnancy, and the biopsy was performed within 2
weeks postpartum, or rarely at Cesarean delivery.
In the New Haven series, the time of biopsy bore no
consistent relation to the pregnancy. Onset of renal
disease is of course approximative, as it only repre-
sents the date when the disease was diagnosed or
became clinically manifest.
Gravidas were classified by morphologic criteria
(for example, focal or diffuse glomerulonephritis,
membranous nephropathy, etc.), except when a
more specific diagnosis could be made, such as
sickle cell nephropathy, IgA nephropathy, amyloi-
dosis, etc., in which cases the women were classi-
fied under the corresponding category. This survey
does not list gravidas with lupus nephropathy, who
are included in the following paper.
Pregnancy outcome was evaluated from records
of the duration of gestation and the infant's birth-
weight. The infant's weight in relation to the gesta-
tional week was correlated with data from 25,608
live births in an urban population (C. H. Hendricks,
unpublished data from University Hospitals of
Cleveland). Apgar scores were recorded at 1 mm in
the Chicago and Newcastle series, and at the time
of leaving the delivery room in the New Haven-
born infants. Thirty-six completed gestational
weeks was taken as the dividing line between pre-
term and term deliveries, and an infant whose birth-
weight was less than 2 SD'S below the mean was
considered "small-for-gestational-age." Both defi-
nitions are in widespread use in current neo-
natology. Abortus and stillborn infants were de-
fined by weight (below and above 500 g, respective-
ly).
The course of maternal renal disease was eval-
uated from four selected parameters: blood pres-
sure, plasma creatinine, blood urea nitrogen
(BUN), and quantitative protein excretion. On rare
occasions when only qualitative urinary protein de-
terminations were available, they are listed in the
tables in parentheses. In the Chicago and New-
castle series, data were obtained before and during
pregnancy, in the postpartum period (within 6
weeks of delivery), and at the end of followup. The
New Haven series includes results obtained during
pregnancy and at the end of followup only. The
blood pressure, concentration of creatinine and
BUN, and amount of protein excreted repre-
sent the highest values measured in each study peri-
od. During pregnancy, they were usually recorded
in the third trimester, most often just before deliv-
ery. Similarly, in the postpartum period, the highest
readings clustered in the first day or two after deliv-
ery.
Of the 89 gravidas, 80 continued to receive their
medical care at the three medical centers or could
be recalled for examination and laboratory testing
at the end of the followup period. The interval be-
tween the index pregnancy and the final assessment
ranged from 3 months to 23 years (mean, 62
months).
The effect of pregnancy on renal function was
studied in more detail, as follows: The 26 women in
the Newcastle series had in 33 pregnancies serial
creatinine clearance determinations on 24-hour
urine specimens before conception, in each trimes-
ter of pregnancy, and 8 to 12 weeks postpartum. Of
these women, 16 had also a 2-hour inulin clearance
(in sitting position) determined in 19 pregnancies at
least once during4 gestation. The highest measure-
ment obtained at any time during pregnancy (usual-
ly in the second trimester) was compared to the val-
ues determined before conception and 8 to 12 weeks
postpartum. Finally, in 7 women of the Chicago se-
ries, renal hemodynamics (inulin clearance as an in-
dex of GFR, and PAH clearance as an index of ef-
fective renal plasma flow) were measured over 2
hours with the women positioned in lateral recum-
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Table 1. Data of pregnant women with diffuse glomerulonephritisa
General information and outcome of pregnancy
Onset
of
Date
of Date
Newborn Before
Patient renal renal of Gestational Wt Apgar BP
no. Center disease biopsy delivery week g scoreb Comments mm Hg
1 CH 1967 PP 7/1972 34 1930 6 Superimposed PE 188/120
2 CH 1964 4/1969 3/1969 33 1900 Stillborn Abruptio placentae with acute
tubular necrosis
3 CH * PP 1/1961 33 1380 "good" 150/110
4
5
CII
CII
*
1956
PP
PP
8/1975
11/1959
28 1100
35 1650
8 Severe PE; Neonatal death,
respiratory distress syndrome 116/66
120/90
6
7
CH
CII
*
*
PP
PP
1/1960
6/1962
12/1963
12/1972
32 1075
38 3825
37 2995
35 3800
"good"
7
8 Superimposed PE
120/70
130/90
130/70
136/60
8 CH * 3/1960 1/1960 38 3530 Superimposed PE
9 CH * 7/1960 3/1960 Delivered elsewhere Superimposed PE
10 CH * 4/1975 1/1975 36 2375 Stillborn Superimposed PE
11 CH 1953 4/1969 5/1970 40 2550 8 140/100
12 CH 1972 8/1972 6/1973 38 3000 10 120/70
13 CH 1952 8/1956 3/1967 40 2915 7 120/80
14 CII * PP 1/1961 36 2825 "good"
15 CH PP 4/1959 34 2545 5 Superimposed PE 120/80
16 CH 1955 PP 8/1959 40 3570 130/70
17 NH 11/1969 1/1970 1/1970 18 — SA
18 NH 6/1968 3/1972 2/1971
12/1971
FT 2330
FT 2200
9
6
Moderate edema
19 NH 2/1969 9/1969 7/1969 28 885 3 Nephrotic
20 NH 10/1970 7/1971 4/1971 FT 2065 8 Nephrotic; hypertension
postpartum
21 NH 6/1961 2/1967 11/1963
2/1967
FT —
FT 2400
Nephrotic
Nephrotic
22 NC 1953 1968 7/1978 36 2160 7 Superimposed PE 140/90
23 NC 1970 1976 1/1979 35 1540 150/95
24 NC 1957 1957 10/1973
2/1977
39 3090
37 3010
8
8
120/80
120/75
25 NC 1972 1973 11/1974
6/1977
26 750
22 600
4
3
Neonatal death
Neonatal death
125/80
105/80
26 NC 1964 1964 11/1975
7/1979
39 3440
39 2180
9
7
115/70
120/80
Abbreviations are as follows: CH, Chicago; NH, New Haven; NC, Newcastle; ', known onset during the index pregnancy;
PP, renal biopsy performed at Cesarean section or within 10 days postpartum; FT, full term, 38 to 42 weeks of gestation; SA,
spontaneous abortion; PE, preeclampsia (superimposed PE represents a chart comment only).
Apgar scores are at 1 mm for the CH and NC series, and on leaving delivery room for NH series.
bency. The tests were done once during pregnancy
(late second or early third trimester), and again 6
weeks postpartum or later.
Serum creatinine, blood urea nitrogen, and urine
protein concentrations were measured at each cen-
ter by the clinical laboratory methods in routine use
at the time of the study. Urine and plasma inulin
concentrations were measured in Newcastle by the
method of Heyrovsky [16] and in Chicago by a mod-
ification of the anthrone method [17]. PAH was
measured by the diazotization method of Smith et al
[18]. Statistical analysis was done with the Stu-
dent's t test for paired samples.
Results
Individual data on all gravidas grouped by type of
renal disease are presented in Tables 1 to 4: These
tables list general information on the mothers' dis-
ease and the infants, with comments on the course
of pregnancy, and maternal blood pressure and ren-
al function before, during, and after pregnancy, and
at the end of the followup period.
There were 121 pregnancies, including 2 pairs of
twins, in 89 women. Distribution of the gravidas ac-
cording to tissue diagnosis is shown in Table 5.
Chronic diffuse and focal glomerulonephntis and
chronic interstitial nephntis accounted for two
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Table 1 (continued)
BP and renal function
pregnancy During pregnancy Postpartum End of followup
Urine Urine Urine Urine
CreatIBUN protein BP CreatJEUN protein BP CreatJBUN protein months BP CreatJBUN protein
mg/dl g/day mm Hg mg/dl g/day mm Hg mg/dl g/day (years) mm Hg mg/dl g/day
200/130
220/160
2.0/24
3.9/37
12.1
4.0
150/108
220/140
1.3/12
23/204
5.4
2.0
60 150/88 1.6/11
/19 0 210/130 /31 4.0 155/110 /20 0.5 31 130/70 /15
0.9/9 0 210/130 1.0/23 8.4 160/120 1.1/23 1.0 20 120/80 0.9/13 0.15
/11
1.0
0
210/170
174/108
/15
/11
4.0
6.2
170/110
154/90
/36
/10
0.2
3.2
/8
1.0/15
0
0
0
120/80
140/80
130/100
160/100
198/110
170/120
142/110
/10
1.3/15
/8
0.8/14
1.3/46
0
0
1.0
4.0
1.0
16.7
14.1
110/70
108/50
120/80
150/100
110/68
100/80
145/110
0.9/6
/20
/10
1.2/13
2.1/46
0
0
4.9
32.0
0
0.7
7.2
(9.5)
66
48
96
34
130/80 0.6/
115/85 0.8/14
192/1 12 /24
120/80 /10
120/80 0.9/13
Transplanted 2/1972
0.1
0.3
0.5
1.2/16 0 110/70 0.8/12 0.1 120/88 0.9/12 0 60 105/60 0.9/14 0
/11 9.6 130/70
188/120
140/110
/10
/13
/18
0.3
2.6
6.7
130/80
155/80
124/94
/10
1.2/7
0
1.1
1.0
(12)
(16)
(18)
130/80 0.8/10
120/75 1.2/18
106/70 0.9/13
0
0.05
0
/10
1.2/16
0.3
0.5
140/100
140/96
130/95
125/80
140/110
110/80
130/90
150/80
140/80
160/105
/15
2.3/43
1.7/13
1.9/28
1.3/15
2.0/43
/28
1.4/17
0.8
(4+)
13.2
(1+)
13.0
6.7
13.0
(4+)
(4+)
3.0
120/70
150/90
/14
1.4/18
0.7
0
(8.3)
(10)
9
(11)
12
Transplanted 8/1970
128/92 1.7/
130/90 1.2/15
110/80 /33
140/80 1.2/13
130/90 1.4/18
5.2
0.9
1.5
(3+)
0.5
0.9/15 0.2 190/110 0.8/13 1.5 160/110 1.1/14 0 6 160/100 1.6/16 0.3
0.8/14 0 120/80 0.7/9 0.7 130/80 0.9/16 0.3
0.9/14 0 120/70 0.8/10 0.5 110/70 1.0/15 0.2 70 110/70 0.9/11 0
0.9/14 1.4 130/70 0.6/10 0.7 110/65 0.8/10 0
1.0/16 1.0 110/80 1.2/15 3.0 105/70 1.1/11 3.0 56 100/75 1.1/19 4.0
0.7/9 0 120/80 0.6/8 0 115/75 0.8/10 0
0.8/11 0 120/80 0.7/7 0 115/80 0.8/13 0 47 115/80 0.8/13 0
thirds of all cases; interstitial nephritis was pre-
dominantly, if not exclusively, of infectious origin
(chronic pyelonephritis), as judged by the clinical
history of recurrent urinary tract infections and
roentgenographic demonstration of collecting sys-
tem abnormalities. The frequency of certain types
of renal disease in this survey reflects, in part, pre-
vailing attitudes of physicians towards conception
in women with kidney disorders: For example, the
high incidence of chronic pyelonephritis in the
Newcastle series is probably due to the fact that ob-
stetricians there discourage pregnancy in women
with glomerulonephritis but not in those with pye-
lointerstitial disease.
Blood pressure and renal function before concep-
tion. These measurements were available for 74 and
70 pregnancies, respectively. Renal function was
adequate (serum creatinine 1.4 mgldl) in all wom-
en, but 15 women were hypertensive before preg-
nancy: Hypertension was severe ( 170/110 mm
Hg) in 3, moderate ( 150/100 mm Hg) in 3 others,
and mild ( 140/90 mm Hg) in 9. Proteinuria was
found in 24 patients, but it was mild ( 1.0 g/day) in
15 and exceeded 3 g/day in only 4 women.
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Table 2. Data of pregnant women with various glomerulopathiesa
27 CH 1970 11/1974 9/1973
28 CH * PP 10/1971
29 CH 1965 PP 9/1971
12/ 1975
30 CH 1970 PP 8/1974
31 CH * PP 11/1971
32 CH 4/1958 6/1958 1/1959
1960
1963
9/ 1965
PP 12/1966
33 CH * PP 10/1972
34 CH 1957 6/1959 3/1964
35 NH 1/1960 9/1960 6/1960
10/ 1962
10/ 1963
11/1964
2/1966
8/ 1968
5/1970
10/1971
7/1975
36 NH 3/1970 2/1972 9/1970
11/1973
37 NH 1/1972 10/1972 7/1972
43 CH * PP 12/1974
44 CH * 11/1975 1975
45 CH * 9/1966 6/1965
46 NH 5/1965 6/1968 12/1965
12/ 1966
47 NH 10/1965 5/1966 10/1969
48 NH 10/1955 6/1959 3/1956
1/1963
49 NH 12/1964 4/1972 7/1964
10/1965
50 CH 7/1976 11/1976 7/1976
51 CH 1964 5/1964 1970
52 CH * PP 6/1972
10/ 1975
8/1977
7/ 1978
53 CH 1959 1964 1971
1966
1975
a Abbreviations are defined in Table 1.
b See footnote b to Table 1.
Focal glomerulonephritis
40 2975 8 S/P right nephrectomy, 1970 130/100
39 1)2850 6
2)2125 6 Twins
40 3250 5 Severe abruptio 154/100
40 4135 9 108/72
36 2105 9 Superimposed PE 170/100
39 3795 10 Superimposed PE
40 3070 110/70
38 3085 120/80
27 1)1580 4 Baby 1) neonatal death (1 day)
2) 850 Stillborn (twins) 120/80
40 3515 10 100/80
40 2910 2 Abruptio placentae, shock 105/65
42 3850 3 Neonatal death (2 days)
40 2925 7 120/80
FT 2350 9 Nephrotic
FT 2370 "good"
FT 2450 8
FT 2125 9
30 — Stillborn
FT 2735 9
FT 2115 9
FT 2560 9
FT 2770 8
FT 3620 9 Gross hematuria
FT 3550 9
FT 3210 9 Nephrosis and hypertensive
postpartum 125/80
Membranous nephropathy
40 3125 9 Stage H
38 2950 Early stage II.
36 2460 8
FT — "good" Nephrotic
FT Nephrotic
FT 2925 9
FT — "good" Nephrotic
FT 2475 9
FT 4950 "good" Nephrotic
FT 4050 "good" Nephrotic
Lipoid nephrosis
38 2800
34 3850
40 2175 9 Nephrotic
40 2260m 10
37 2325 6
40 2200 8
Focal glomerulosclerosis
39 2660 Anasarca
Patient
General information and outcome of pregnancy
Onset
of
renal
Date
of
renal
Date
of
Newborn
-
Before
BPGestational Wt Apgar
no. Center disease biopsy delivery week g scoreb Comments mm Hg
38 NC 1963 1970 6/1978 38 2740 8
Membranoprolferative glomerulonephritis
39 NH 3/1969 6/1971 6/1971 FT 2850 9
40 NH 12/1969 5/1971 6/1972 FT 2830 9
41 NH 1/1965 8/1975 8/1979 FT 2076 9 Nephrotic
42 NC 1969 1969 9/1978 38 3210 8 Type II. Also, partial lipodystro-
phy 130/85
120/60
120/80
130/70
140/ 100
100/60
110/60
112/60
120/70
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Table 2 (continued)
BP and renal function
Postpartum
Unne Urine Urine Urine
CreatiBUN protein BP CreatJBUN protein BP CreatJBUN protein months BP CreatJBUN protein
mg/dl g/day mm Hg mg/dl glday mm Hg mg/dl glday (years) mm Hg mgldl g/day
1.0/24 (3+) 160/120
1.1/8 0 110/70
/10 1.5 110/70
/10 100/60
/9 0.5 108/68
/11 4.0 128/80
(Neg) 140/90
/9 (Neg) 124/82
120/80
120/80
120/80
120/70
120/88
120/80
128/90
110/70
120/80
120/80
120/80
130/90
2.3 120/80
4.4 120/80
1.6 105/65
1.1 115/75
0.9
(Neg) 120/65
14.7
0.3
0.1
0
0
0
0
0.2
0.2
(2+)
0.5
0.9
3.0
4.0
0.7 (18) 130/80
0.8 82 110/80
(Neg) 20 130/85
1.1/15
0.8/10
0.9/ 0 160/1 10 0.8/12 0 140/80 1.0/12 0 12 140/85 1.0/12 0
0,8/20
0.9/9
1.0/10
0.8/9
12.0
0.2 138/90
0.1 120/80
120/80
0.2 128/60
120/85 0.6/13
12.3 110/60 1.0/10
120/70 0.8/9
106/80 0.8/
0.3 114/80
11.9 21 110/80
96 120/80
5.8
0.2
0.3
84 120/88
/7 3.4 Delivered elsewhere 115/80 0.7/9 8.5 84 132/82 1.5/25
On hemodialysis since 12/1979
15.0
pregnancy During pregnancy End of follow-up
0.9/17 0.4 160/100
0.7/6 0 150/120
0.7/10 1.9 170/122
0 180/120
/10 0 130/70
7.6 180/100
0 130/90
0 190/124
0 140/88
(3+) 130/90
1.2 130/90
7.2 115/65
6.2 76 130/90
0
1.2/16 (4+)1.2/23
1.1/
0.9/6
1.0/11
0.9/8
/10
/9
/9
/9
/17
0.6/5
/10
0
0 71 120/88 0.8/12
5.6 42 140/110 1.2/13
0.6 29 134/70 0.9/8
1.5
1.0/13
1.1/6
0.8/10
/10
0.8/15
1.2/18
0.8/12
/12
/9
/8
0.9/17
0.6/5
/9
0.9/8
0.8/8
1.0/7
0.6/6
0.7/6
/10
0.9/13
0.8/7
0
2.0
(Neg)
1.4
0
0
0.8/10
1.0/13
1.1/10
1.0/16
(14) 102/80 /12 0.2
33 110/90 0.9/13 0.2
39 130/80 0.9/11 0.2
120/70
150/94
150/100
0 135/90
1.0 120/80
0 120/74
0.5 114/70
120/90
120/80
130/90
148/ 100
150/90
130/80
130/90
0.8/12
1.2/8
1.0/16
3.0
(2+)
10.0
0.8 130/90
8.5 120/80
7.9
2.6 130/80
10.0
(3+)
0
(4+)
0.2
(2+)
4.1
1.1/20
0.8/13
0.8/30
0.7/9
0.8/5
0.8/8
0.8/li
0.7/9
1.1/6
/20
1.0/7
/9
0.8/10
1.0/20
1.3/22
0.6/6
0.8/9
4 120/80 1.0/21
(12) 120/80 1.0/15
2 120/70 0.9/13
0 12 150/100 0.8/14
4.8 57 140/85 0.5/11
14 140/50 0.7/10
2.9 (13) 140/94 1.1/13
24 120/80 /11
(9) 150/100 0.9/13
(23) 148/82 0.8/15
92 110/70 1.1/10
1.1/9
0.9/7
4.0
(2+)
4.0
1.0
2.3
0.4
2.0
(1+)
0
1.4
7.8
0
0.5
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Table 3. Data of pregnant women with chronic interstitial nephritis
General information and outcome of pregnancy
Onset Date
Newborn
Date
Patient of renal of renal of Wt Apgar
no. Center disease biopsy delivery Gestational week g scoret Comments
54 CH 1965 11/1970 8/1971 40 4420 7 Right nephrectomy, 1970. Calculi.
55 CH PP 4/1965 40 3265 6
56 CH 1970 2/1973 7/1977 21 350 SA (Cord prolapse). Horseshoe kidney;
partial nephrectomy, 1973
57 NC 1970 1972
2/1979 40 3705
5/1979 40 2640
9
8
58 NC 1964 1964 2/1979 40 3380 8 Right nephrectomy, 1965
59 NC 1974 1975 8/1977 40 2640 9
60 NC 1972 1974 10/1975 37 2960 8
61 NC Childhood 1965 2/1978 38 3310 8
62 NC 1967 1968 8/1974 39 3100 8
63 NC 1966 1967 5/1974 35 2310 6
64 NC 1971 1973 12/1978 39 3330 9
65 NC 1976 1976 7/1977 38 2420 6
66 NC 1972 1973 10/1978 36 1870 7
67 NC 1974 1974 2/1977 36 2970
68 NC 1975 1976 6/1978 40 3810 8
69 NC 1972 1974 5/1975 40 3260 8
70 NC 1967 1971 3/1976 37 3310 8
71 NC 1971 1972 2/1978 40 2230
3/1979 39 3620
6
8
Right duplex kidney, neonatal death, air embolism
72 NC 1973 1973 12/1975 38 3300
10/1978 39 4330
6
8
73 NC 1959 1959 2/1975 36 2490
10/1977 39 3035
8
8
Left nephrectomy, 1960; Ileal bladder, 1963
74 NC 1972 9/1976 40 2940
1/1979 41 3170
8
9
a Abbreviations are defined in Table 1.
b See footnote b to Table 1.
Outcome of pregnancy. Data on the newborn and
the duration of gestation are summarized in Table 5.
In the entire series, 7 pregnancies ended in fetal
death (spontaneous abortions beyond the first tri-
mester and stillbirths), and 5 of them were in wom-
en with diffuse or focal glomerulonephritis. There
were 6 instances of neonatal death, and all but one
were from women in the same two diagnostic
groups.
Twenty-four deliveries (20%) were preterm ( 36
weeks gestation), with more than half of them in
women with diffuse glomerulonephritis. Of the 111
infants whose birthweight was known, 70 were
above 2500 g, 25 between 2000 and 2500 g, and 16
below 2000 g. Birthweight in relation to gestational
age for all pregnancies is plotted in Fig. 1. There
were 27 small-for-gestational-age (SGA) infants
(24,3% of all live births), distributed fairly evenly
along the entire spectrum of maternal renal disease.
Interestingly, the majority of SGA infants (20 out of
27) were delivered at or near term, but only 1 of the
6 infants who died in the neonatal period was small-
for-date.
Effect of pregnancy on preexisting renal disease
(Table 6). The immediate and remote effects of
pregnancy on the course of renal disease in the
mother were evaluated from the changes in blood
pressure, renal function, and protein excretion dur-
ing gestation and postpartum in each pregnancy and
at the end of the followup period. Functional deteri-
oration was defined by a set of arbitrary criteria for
blood pressure, BUN, creatinine and protein excre-
tion (see Table 6), which represent either frankly
abnormal measurements or a substantial worsening
compared to prepregnancy levels. We emphasize
that these criteria do not define impaired renal func-
tion in normal pregnancy, but were chosen to in-
dicate probable further deterioration in women with
established kidney disease before conception.
Significant hypertension was noted in 23% of all
pregnancies. It was both more common and more
severe in women with diffuse glomerulonephritis,
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Table 3 (continued)
BP and renal function
Before pregnancy During pregnancy Postpartum End offollowup
Urine Urine Urine Urine
BP Creat/BUN protein BP Creat/BUN protein BP Creat/BUN protein Months BE Creat/BUN protein
mm Hg mg/dl glday mm Hg mg/dl glday mm Hg mg/dl glday (years) mm Hg mg/dl giday
140/90 1.0/9 0 144/80 0.8/10 0 120/85 0.9/7 0.04 87 135/90 1.1/19 0.6
/12 130/90 /12 0.6 120/80 /12 0.4 (12) 0.8/10 0.3
125/70 0.7/9 0 110/70 0.7/5 0 100/70 0.8/6 0
110/80 1.0/9 0.2 150/80 0.8/6 (1+) 24 120/80 1.0/10
115/70 0.9/13 0 110/70 0.8/9 0 105/65 0.9/12 0 3 100/65 0.9/12 0
105/75 0.9/16 0 115/75 0.9/17 0.5 110/80 1.0/15 0 7 115/70 1.0/15 0
110/70 0.9/15 0 120/75 0.7/10 0 110/80 0.9/16 0 12 115/80 0.9/14 0
130/80 0.8/14 0 150/95 0.7/14 0 130/90 1.0/16 0 34 125/75 0.9/18 0
135/95 1.0/18 0 150/100 1.0/18 0.3 140/95 1.1/20 0 8 130/90 1.0/19 0
120/80 1.2/14 0 135/90 0.8/9 0.5 120/80 1.1/12 0 24 130/80 1.1/15 0
115/80 0.9/12 0 130/85 0.9/10 1.0 120/80 1.1/16 0
130/80 0.9/14 0 120/80 0.9/10 0 115/75 1.0/13 0 3 115/75 1.0/13 0
115/70 0.8/12 0 140/90 0.7/9 0.25 115/75 0.8/16 0 12 115/80 0.8/14 0
140/90 1.0/19 0.3 160/110 0.8/15 0.7 140/90 1.0/18 0
115/80 0.9/15 0 130/90 0.7/11 0.5 115/75 0.8/13 0.2 16 120/75 0.9/13 0
120/80 0.9/12 0 120/80 0.9/9 0 120/70 1.0/13 0 12 100/70 1.0/13 0
125/70 1.2/17 0 120/90 1.0/11 0.2 130/70 1.2/21 0 48 130/85 1.0/19 0
120/75 1.0/19 0 150/100 0.8/14 0.5 130/80 0.9/19 0 12 130/80 0.8/18 0
120/75 0.9/15 0 150/95 0.7/9 0.5 140/90 1.0/18 0.2
140/90 1.0/18 0.2 140/95 0.6/9 0.2 140/90 0.8/11 0 16 140/90 08/11 0
120/75 0.9/15 0 150/100 1.0/14 0 120/80 1.0/15 0
110/70 0.8/14 0 130/85 0.8/10 0 130/80 1.1/15 0 37 130/80 1.1/15 0
120/70 0.8/12 0 125/85 1.0/13 0 120/80 1.3/15 0
120/80 1.3/15 115/70 1.2/13 0.5 120/80 1.2/13 0 35 120/80 1.2/13 0
120/75 1.1/17 0 110/75 0.8/13 0 120/80 1.1/19 0
120/75 1.0/16 0 110/70 0.9/10 0 120/70 1.0/19 0 31 120/70 1.0/19 0
but there was also a substantial incidence of hyper-
tension in women with focal glomerulonephntis
and, not surprisingly, arteriolar nephrosclerosis.
Blood pressure elevations were particularly fre-
quent in women from the Chicago series in whom
they often reached extreme levels. This reflects in
part the large proportion of black patients in this
population, as well as the fact that many of them
were 'selected" (that is, brought to the nephrolo-
gist's attention) by the hypertensive complication of
their gestation. These levels were not sustained,
however, as they usually occurred only shortly be-
fore (or after) delivery, and were promptly treated.
Approximately one half of the women who devel-
oped moderate to severe hypertension during preg-
nancy had been normotensive before conception.
Renal function decreased in 16% of all preg-
nancies in this series, most often in women with dif-
fuse glomerulonephritis (11 of 19). In general, the
decrement in renal function was only mild to mod-
erate, and reversed after delivery. In two gravidas
(patients 2 and 80) the marked deterioration of renal
function during pregnancy was due to acute tubular
necrosis. In 3 women with moderate renal in-
sufficiency during gestation (patients 11, 17, and
85), the pregnancy seems to have occurred during
the downhill phase of the disease, which eventually
progressed to end-stage renal failure. In another
woman (patient 83, sickle cell nephropathy), a mod-
erately severe decrease in renal function occurred
postpartum in association with extensive renal vein
thrombosis, which was treated successfully with
anticoagulants. Finally, 6 women with chronic py-
elonephritis had one or more episodes of acute uri-
nary tract infection during pregnancy, which did not
affect renal function adversely.
Increased proteinuria was the most common ren-
al effect of gestation, possibly reflecting, in part, the
tendency to increased protein excretion seen in nor-
mal gravidas as well [5, 6]. Severe or substantially
increased proteinuria was manifest in nearly half of
the pregnancies in this series (57 of 121) and oc-
curred in nearly all types of renal disease, although
it was uncommon in women with chronic interstitial
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Table. 4. Data of pregnant women with arteriolar nephrosclerosis and miscellaneous renal disordersa
Pa-
Onset
of
renal
Date
of
General information and outcome of pregnancy
Date
Newborn
Gesta-
tient Cen- dis- renal of tional Weight Apgar
no. ter ease biopsy delivery week g scor& Comments
75 CH * PP 1/1977
Arteriolar nephrosclerosis
40 2875 7 Superimposed PE
76 CII * PP 3/1965 36 1800 3
77 CH * PP 11/1970 40 3456
78 CII PP 8/1977 39 1490 7
79 CII 1957 PP 10/1961 41 3325
80 CII * 10/1971 9/1971 36 1410 2 Superimposed PE, probable acute tubular necrosis
81 CII PP 1/1958 36 2000 "good" Superimposed PE
82 NC 1976 1977 10/1978 39 3630 8
83 CH — PP 7/1976
Sickle-cell nephropathy
38 2845 9 Extensive renal vein thrombosis
84 CH — PP 12/1975 26 535 Stillborn
85 CII — PP 5/1973
Polycystic kidney disease
37 2015 9 Eclampsia
86 CII * PP 1/1971
Diabetic glomerulosclerosis
40 4075 7
87 CH * 12/1975 7/1975
IgA nephropathy
41 3485 "good"
88 CH A 12/1970
2/1973
6/1970
Renal amyloidosis
28 1020
89 CH 11/1969 — 8/1971
Bilateral renal artery stenosis
37 2830 8
Abbreviations are defined in Table 1.
b See footnote b of Table I.
nephritis. Proteinuria occurred de novo during
pregnancy in 15 of the 24 proteinuric women whose
prepregnancy urine protein determinations were
available. Protein excretion was massive, exceed-
ing 3 g!day in 39 of the 57 pregnancies (68%), and
led frequently to nephrotic edema.
"Superimposed preeclampsia" was diagnosed on
clinical grounds in 13 women, and eclampsia in 1 by
the attending obstetricians, although only 4 of these
women were normotensive and had protein-free
urine before conception. In 13 women in this group,
a renal biopsy was performed postpartum; the
biopsy revealed the characteristic glomerular
changes of preeclampsia in only 7 gravidas, includ-
ing the one with eclampsia. These results confirm
our conclusion that the diagnosis of preeclampsia
cannot be made with certainty on clinical grounds
alone [19]. This is especially true in women with co-
existent renal disorders, in whom hypertension and
proteinuria may be manifestations of the underlying
disease.
At the end of followup, the prevalence of hyper-
tension or renal function abnormalities, as well as
their severity, were considerably less than during
pregnancy and the postpartum period. Eighty wom-
en were studied 3 months to 23 years after the index
pregnancy. Apart from the 5 patients who pro-
gressed to end-stage renal failure and are discussed
below, only 1 woman had moderately severe hyper-
tension; 7 others had mild hypertension, but 4 of
them were also hypertensive before the index preg-
nancy. Renal function decreased slightly in only 5
women, their highest creatinine and BUN concen-
trations being 1.7 and 33 mgldl, respectively. Final-
ly, abnormal proteinuria was found in 23 women,
(plus 5 others who were proteinuric before preg-
nancy). In contrast to the situation in pregnancy,
however, the amount of protein excreted was small
in the majority of cases, and exceeded 3.0 g/day in
only 5 patients.
As indicated, 5 patients progressed to end-stage
kidney disease. Their diagnoses were diffuse gb-
merulonephritis in 2 women, and focal glomeru-
losclerosis, polycystic kidney disease, and renal
amyloidosis in I each. Of these women, 3 are re-
ceiving maintenance hemodialysis, and 2 have been
Kidney disease and pregnancy
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BP and renal function
Before pregnancy During pregnancy Postpartum End of followup
Urine Urine Urine Urine
BP CreatJBUN protein BP Creat/BUN protein BP Creat/BUN protein months BP Creat/BUN protein
mm Hg mg/dl g/day mm Hg mgldl glday mm Hg mg/dl g/day (years) mm Hg mg/dl g/day
/8
120/85 1.3/15
140/100
170/110 1.0/10
115/60
140/85 1.0/15
160/110 1.3/8 0.3 144/96 1.0/6
150/105 /12 0.4 140/80 /12
140/100 1.0/15 0 130/80 0.8/15
160/120 0.8/9 0 110/76 1.3/15
0 160/100 0.9/12 0 200/130 0.9/12
0 280/160 9.6/101 1.0 120/80 1.1/21
186/106 8.0 165/100
0 130/85 0.9/11 0.3 130/85 0.9/13
140/85 1.0/10 (Neg) 150/80 2.2/34
240/140 1.5/20 2.0 170/110 1.4/13
0.5 9 130/80 0.7/9
0.1 (12) 0.9/9
0
5.3 7 120/86 0.8/9
0.6 (18) 130/76 1.1/12
4.0 75 150/105 1.1/13
0 3 130/85 0.9/13
4.4 23 125/85 0.8/6
1.4 4 130/80 1.4/14
120/70 0 185/140 2.5/39 7.0 170/1 10 2.2/27 5.7 On hemodialysis since 11/1979
0 130/80 1.1/12 0 130/75 /12 0.4
/10 160/110 1.0/11 (3+) 140/90 1.1/15 2.0 25 135/90 0.9/11 2.5
130/80 1.1/20 5.3 140/90 1.1/24 8.6 On hemodialysis since 2/1975
190/124 0.8/12 0 172/106 1.0/12 0 150/98 0.9/10 0 79 140/90 1.0/13 (Neg)
Table 5. Classification of renal disease and outcome of pregnancya
Preg- Fetal Neonatal Preterm
Small-for-
gestational-
age
Birthweight live infantsb
1500 to 2000 to
Diagnosis Gravidas nancies deathsa deaths deliveries infants 1500 g 2000 g 2500 g >2500 g
Diffuse glomerulonephritis 26 33 3 3 13 9 6 3 6 13
Focal glomerulonephritis 12 26 2 2 1 6 0 1 7 18
Membranoproliferative
glomerulonephritis 4 4 0 0 0 1 0 0 1 3
Membranous nephropathy 7 10 0 0 1 1 0 0 2 5
Lipoid nephrosis 3 6 0 0 1 4 0 0 4 2
Focal glomerulosclerosis 1 1 0 0 0 0 0 0 0 1
Interstitial nephritis 21 26 1 1 4 2 0 1 4 20
Arteriolar nephrosclerosis 8 8 0 0 3 3 2 2 0 4
Sickle-cell nephropathy 2 2 1 0 0 0 0 0 0 1
Polycystic kidney disease 1 1 0 0 0 1 0 0 1 0
IgA nephropathy 1 1 0 0 0 0 0 0 0 1
Diabetic glomerulosclerosis 1 1 0 0 0 0 0 0 0 1
Renal amyloidosis 1 1 0 0 1 0 1 0 0 0
Bilateral renal artery stenosis 1 1 0 0 0 0 0 0 0 1
Totals 89 121c 7 6 24 27 9 7 25 70
Percent 5.7% 4.9% 20.0% 24.3% 8.1% 6.3% 22.5% 63.1%
a Stillbirths and 2nd trimester spontaneous abortions
' Birthweight available for only 111 of the 116 live infants
Two sets of twins
150/70 1.4/19
0.2
0.3
0
0
0.5
0
2.6
0
highest levels during each period. When renal he-
modynamics were measured prospectively with
clearance methods, we observed an increment in
both GFR and ERPF similar to that seen in normal
gravidas. Thus, serial measurements of creatinine
clearance in each trimester of 33 pregnancies from
the Newcastle series indicate that although mean
creatinine clearance in gravidas with renal disease
was 1 SD or more below that of normal pregnant
women, the increase in this measurement produced
by pregnancy was essentially identical in the two
groups (Fig. 2). The increment in GFR during preg-
nancy was confirmed in 16 of these women with the
2-hour inulin clearance test (Fig. 3). Similar in-
crements in both GFR and ERPF were noted in a
smaller number of gravidas in the Chicago series
(Fig. 4); the higher rates of inulin clearance in this
group can probably be explained by the fact that the
gravidas were studied in lateral recumbency. It is
noteworthy that, among the women studied in Chi-
cago, there were 2 with a single kidney (following
surgical nephrectomy), in whom additional in-
crements in renal hemodynamics must have oc-
curred on top of the already maximal compensatory
increase in renal function, and I woman with bilat-
eral renal artery stenosis, in whom a pregnancy-in-
duced increase in renal blood flow was considered
unlikely for hemodynamic reasons.
transplanted after brief periods of dialytic treat-
ment. The onset of end-stage renal failure varied be-
tween several weeks and over 8 years after deliv-
ery, and therefore bore no consistent temporal rela-
tion to pregnancy.
The last part of this analysis deals with renal he-
modynamics during pregnancy. Because both GFR
and effective renal plasma flow (ERPF) increase
during normal gestation [3, 6], it was of interest to
verify whether this phenomenon also occurs in the
presence of renal parenchymal or vascular disease.
In this series, serum concentrations of creatinine
and/or urea nitrogen decreased moderately in ap-
proximately half the pregnancies for which measure-
ments were also available before conception. These
determinations are, however, but a crude index of
glomerular filtration and, in addition, represent the
Discussion
This study was organized to evaluate the out-
come of pregnancy in women with preexisting renal
disorders and the effect of gestation on the course of
their underlying disease. The relatively large num-
ber of women studied, the fact that their diagnosis
was established by kidney biopsy, and the variety
of geographic locations and types of medical prac-
tice from which they originated lend in our opinion
validity to the conclusions obtained from this sur-
vey. Nevertheless, it is important to recognize that
the patients reported herein constitute a sample
biased towards those with more advanced renal in-
volvement or complicated gestation: First, all three
institutions are referral centers that treat a larger
proportion of more severe cases. Second, the ma-
jority of women in the Chicago series (which com-
prises over half of the cases in this report) were un-
aware of antecedent renal disease or hypertension,
and represent therefore a subpopulation of patients
"selected" for inclusion in the study by the propen-
sity of their disease to become clinically manifest
during pregnancy.
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Fig. 1. Birthweight in relation to gestational age for all live in-
fants. Lines represent mean weight I and 2 so of 25,608 live
births at University Hospitals of Cleveland between 1958 and
1968 (courtesy of Dr. C. H. Hendricks).
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Considering the inclusion in this survey of wom-
en with more severe disease and/or an increased
tendency of pregnancy to bring it to the fore, its re-
suits are encouraging: Although the pregnancy itself
was often complicated by hypertension or nephrotic
edema, we did not find any evidence that gestation
affects adversely the natural course of the under-
lying renal disease. The incidence of preterm deliv-
eries, small-for-date infants, and fetal deaths were
higher than they were in the general population of
gravidas. Nonetheless, the frequency of these
events was not excessive and, in our view, does not
warrant advising women with renal disease against
undertaking pregnancy, provided the gestation can
be closely supervised.
There were 116 live births from a total of 123 fe-
tuses (94.3%). The 5 stillbirths (4.1%) represent a
higher fetal loss than do the corresponding rates for
all gravidas of 1.2% nationwide in the United
States, and 1.4% at the high-risk obstetrics referral
center at Chicago Lying-in Hospital (CLIH); the oc-
currence of 2 late abortions (1.6%) was probably
not different from the incidence of this complication
in the general population (precise statistics on this
point are not available). In addition, there were 6
neonatal deaths (4.9%), compared to 0.8% nation-
wide and 1.8% at CLIH. (Statistics of neonatal
deaths are more difficult to interpret, because their
relation to the health of the mother is not always
clear; for example, one infant in this series died 2
days after birth of air embolism.) Perinatal mortality
(stillbirths plus neonatal deaths) was 9%, which is
considerably higher than the corresponding rate in
the general population (2% nationwide; 3.2% at
CLIH). It should be noted, however, that all the fig-
ures for the normal gravidas are current and are on-
ly half as much as they were in 1960, in the first
years of this survey. Interestingly, although most of
the nonviable infants or those who died in the neo-
natal period were delivered prematurely and were
consequently of low birth weight, only 2 were
small-for-gestational-age, indicating that intra-
uterine growth retardation was not a prominent fac-
tor in the poor outcome of these pregnancies.
The incidence of preterm deliveries (20%) and es-
pecially that of infants small-for-gestational-age
(24.3%) were substantially above the corresponding
rates for all gravidas (13.3 and 5.7%, respectively,
at CLIH). The prematurity figures, however, re-
flect, in part, medical decision, as many of these
pregnancies were induced medically or terminated
by Cesarean section because of concern for mater-
nal well-being.
The majority of the 13 infants who did not survive
were born of mothers with glomerulonephritis (6
diffuse and 4 focal glomerulonephritis), an in-
cidence higher than that of these two entities in the
entire series. Beyond this correlation, however, no
clear relationship emerges between fetal or neonatal
loss and maternal renal disease. Most of the
mothers had normal renal function during the preg-
nancy and, in those for whom measurements were
available, before conception as well. Preexistent
hypertension, another factor that influences ad-
versely the outcome of pregnancy [1-7, 9] was not
found in any of the women in this group studied be-
fore conception. Of these women, however, 4 of
them developed severe and 3 mild hypertension
during the unsuccessful pregnancy, and 5 women
had massive proteinuria in excess of 3 g/day. It
should also be noted that several of these women
had multiple pregnancies and delivered full-term,
healthy babies before or after (or both) the preg-
nancy that ended in fetal or neonatal death.
A major aim of this study was to determine the
immediate and remote effects of gestation on the
mother's renal disease. The results indicate rather
clearly that although renal disease may become
clinically manifest or worsen during pregnancy (es-
pecially as severe hypertension or nephrotic pro-
teinuria), its natural course is probably not affected
by gestation. Only 5 of the 80 women available for
followup study progressed to end-stage renal fail-
ure. Although it is not possible to affirm or deny
with certainty whether the pregnancy accelerated
the rate of progression of the disease in these wom-
en beyond what it would have been had they not
conceived, some insight into this question could be
gained from examination of the temporal relation-
ship between pregnancy and the onset of renal fail-
ure: In the patient with focal glomerulosclerosis,
renal failure requiring dialytic treatment occurred 8
years after delivery; 7 years after delivery, BUN
and serum creatinine were still 25 and 1.5 mg/dl, re-
spectively. Similarly, the woman with renal amyloi-
dosis was not started on hemodialysis until nearly 5
years after her pregnancy, and the patient with
polycystic kidney disease until 6.5 years later. A
fourth patient reached end-stage renal failure 20
months after her pregnancy, but her renal function
improved after delivery and remained stable at a
moderately decreased level (creatinine, 1.5 mg/dl;
BUN, 24 mg/dl) for 12 months thereafter. It is rea-
sonable to conclude that in these 4 women there
was no connection between pregnancy and the out-
come of their renal disease. The situation was less
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Table 6. Effect of pregnancy on maternal renal disease
Course during pregnancy or postpartum Status at the end offollowup
Decreased Decreased
Preg- Hyper- renal Increased Hyper- renal Increased
Diagnosis nancies tensiona fuflctionb proteinuria' Gravidas tension' functio&' ESRDd proteinuria'
Diffuse glomerulonephritis 33 11 11 24 23 1 3 2 7
Focal glomerulonephritis 26 6 2 9 11 0 2 0 0
Membranoproliferative
glomerulonephntis 4 0 1 3 4 0 0 0 4
Membranous nephropathy 10 0 0 8 7 0 0 0 6
Lipoid nephrosis 6 0 0 2 3 0 0 0 0
Focal glomeruloscierosis 1 0 0 1 1 — — 1 —
Interstitial nephritis 26 3 1 2 19 0 0 0 2
Arteriolar nephrosclerosis 8 5 2 3 6 0 0 0 2
Sickle-cell nephropathy 2 1 1 2 2 0 0 0 1
Polycystic kidney disease 1 1 1 1 1 — — I —
IgA nephropathy 1 1 0 1 1 0 0 0 1
Diabetic glomerulosclerosis 1 0 0 0
Renal amyloidosis 1 0 0 1 1 — — I —.
Bilateral renal artery stenosis 1 0 0 0 1 0 0 0 0
Totals 121 28 19 57 80 1 5 5 23
Percent 23.1 15.7 47.1 1.3 6.3 6.3 28.8
a Blood pressure  160/110 mm Hg or increased  30/20 mm Hg above prepregnancy levels.
b BUN  25 mg/dl or serum creatinine  1.5 mg/dl, or increased 50% or more above prepregnancy in any of these two measurements
Twenty-four-hour protein excretion  3.0 g, or 100% or more above prepregnancy level, or  1.0 g/day or  2+ ( 0.3 g/day or
 1+ at the end of followup) if prepregnancy measurements not available or negative.
d End-stage renal disease (patient on maintenance hemodialysis or after transplantation). These patients were not counted in the other
categories (hypertension, proteinuria, etc.).
clear in one patient who developed end-stage renal
failure several weeks after an unsuccessful preg-
nancy. This woman, however, had crescentic, dif-
fuse glomerulonephritis, and it was the impression
of her attending nephrologist that pregnancy super-
vened during the rapidly progressive stage of her
disease and did not affect its inexorable course. We
conclude, therefore, that in this series the small
number of women who reached end-stage renal fail-
ure had diseases that carry an ominous prognosis
and were likely to have progressed in the same way
regardless of the intervening pregnancy.
Because none of the women in this survey had
overt renal insufficiency before pregnancy, the fore-
going comments and conclusions obviously apply
only to gravidas with preserved renal function at
conception. This is an important distinction, as the
outcome of pregnancy is reportedly poorer in wom-
en with impaired renal function [1-3, 5, 6], in whom
a deleterious effect of gestation on the underlying
disease has also been suggested [2, 13—15]. We can
comment, however, on women with preexisting hy-
pertension of whom there were 15 in this series, 6 of
them with moderately severe and 9 with mild hyper-
tension. The pregnancy in some of these patients
had a hectic course, marked sometimes by extreme
blood pressure elevations, and in 1 woman each by
abruptio placentae and acute tubular necrosis.
There were 8 preterm deliveries with 4 of the infants
being also small-for-date. There were no fetal or
neonatal deaths in this group, however, and only 1
of the 13 women (diffuse glomerulonephritis) pro-
gressed to end-stage renal failure.
Summary and conclusions. In a cooperative,
combined prospective and retrospective study, we
analyzed the outcome of 121 pregnancies in 89
women with various renal disorders, and the effect
of gestation on the course of their underlying dis-
ease. In all but 1 patient the diagnosis was estab-
lished by renal biopsy, and all women had normal or
only slightly impaired renal function before concep-
tion. Gravidas were studied between 1956 and 1979,
and the period of followup ranged between 3
months and 23 years (average, 62 months).
Despite the fact that this population had poten-
tially serious disease, there were 116 live births
from a total of 123 fetuses. The incidence of fetal
loss, neonatal mortality, preterm deliveries, and
small-for-gestational-age infants was, however,
moderately higher than were the corresponding
rates for all gravidas.
The following maternal complications were en-
countered: Increased proteinuria (in some cases
massive) was seen in nearly one half of these preg-
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Fig. 2. Serial 24-hour creatinine clearance determinations (mean
1 SD) in 33 pregnancies of 26 gravidas with renal disease stud-
ied before conception, in each trimester, and 8 to 12 weeks post-
partum (solid line). Measurements in 10 normal gravidas (mean
1 SD) areshown in hatched area (Newcastle series). Creatinine
clearance increased during pregnancy both in normal women and
in those with renal disease.
nancies, and significant hypertension occurred in
23% (many of the latter gravidas, however, were in-
cluded in the survey because of the detection of hy-
pertension during pregnancy or at term). Renal
function decreased in 16% of the pregnancies, but
the decrement was usually mild to moderate and re-
versed after delivery. Two gestations were corn-
Fig. 3. Two-hour inulin clearance in 19 pregnancies of 16 gravi-
das with renal disease studied before, during, and after preg-
nancy (Newcastle series). A significant increase occurred during
gestation.
plicated by acute tubular necrosis (following severe
preeclampsia and abruptio placentae, respectively),
and one by renal vein thrombosis in a woman with
sickle cell nephropathy. Measurements of renal he-
modynamics performed serially during gestation
and either before conception or after delivery in-
dicate that both GFR and effective renal plasma
Fig. 4. Renal hemodynamics in 7 gravidas with various renal disorders (Chicago series). Both GFR (inulin clearance) and ERPF (PAH
clearance) were significantly higher during pregnancy than in the postpartum period.
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flow increase during pregnancy in women with un-
derlying renal disease as they do in healthy gravi-
das.
In contrast to the relative frequency of maternal
complications during pregnancy, the prevalence
and the severity of hypertension or renal function
abnormalities were considerably less at the end of
followup. Only 5 of the 80 patients developed end-
stage renal disease, the onset of which bore no con-
sistent temporal relationship to the gestation. These
patients had renal disorders that carry a poor prog-
nosis, and we found no evidence that the inter-
vening pregnancy accelerated the progression of
their disease.
Considering the inclusion in this survey of many
women whose renal disease was brought to clinical
expression by the pregnancy (and therefore repre-
sent in this sense a "selected" subpopulation), its
results are encouraging: The frequency of fetal or
neonatal deaths, although moderately higher than it
is in healthy gravidas, does not warrant, in our opin-
ion, discouraging women with renal disease from
becoming pregnant. Whereas maternal complica-
tions are not infrequent and indicate the need for
close supervision of the gestation, the natural
course of the underlying disease is probably not af-
fected adversely. Because none of the women sur-
veyed had overt renal insufficiency prior to concep-
tion, the foregoing comments and conclusions obvi-
ously apply only to gravidas with preserved renal
function. Finally, there is still a need for multicenter
prospective studies that aim not only at determining
the remote prognosis of gravidas with renal disease,
but also the long-term outcome of their infants.
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